mhurhangee/ep-ind-claims huggingface dataset:
A computer-implemented method for diagnosing mastitis in a lactating and preferably bovine animal, the method comprising: - recording data, the data having been obtained from analyzing a series of milk samples, the series of milk samples in turn having been obtained by periodically milking an animal, the data including total leukocyte count or somatic cell count as well as differential leukocyte counts and changes in these counts between subsequent samples, wherein the differential leukocyte counts include the lymphocyte count, the macrophage count and the neutrophil count; and - evaluating the recorded data to obtain information on the presence of mastitis, on the microorganism responsible for mastitis and, optionally, on the stage of mastitis; wherein evaluating the recorded data includes: determining mean values and confidence intervals for the TLC or SCC and each of the differential leukocyte counts L, M and N; assigning the samples to threshold groups based on the mean value of the TLC or the SCC; evaluating whether the TLC or SCC of a new sample enters a higher threshold group and, if applicable, which threshold group has been entered; and evaluating whether a threshold group has been exceeded and, if so, evaluating the recorded data to obtain information on the microorganism responsible for mastitis, wherein the prediction of a specific microorganism is made based on information regarding peak TLC or SCC in previous samples, length of the plateau before the TLC or SCC decreases, and the change in percentages of N, M and L during a number of previous samplings. - recording data, the data having been obtained from analyzing a series of milk samples, the series of milk samples in turn having been obtained by periodically milking an animal, the data including total leukocyte count or somatic cell count as well as differential leukocyte counts and changes in these counts between subsequent samples, wherein the differential leukocyte counts include the lymphocyte count, the macrophage count and the neutrophil count; and - evaluating the recorded data to obtain information on the presence of mastitis, on the microorganism responsible for mastitis and, optionally, on the stage of mastitis; determining mean values and confidence intervals for the TLC or SCC and each of the differential leukocyte counts L, M and N; assigning the samples to threshold groups based on the mean value of the TLC or the SCC; evaluating whether the TLC or SCC of a new sample enters a higher threshold group and, if applicable, which threshold group has been entered; and evaluating whether a threshold group has been exceeded and, if so, evaluating the recorded data to obtain information on the microorganism responsible for mastitis, wherein the prediction of a specific microorganism is made based on information regarding peak TLC or SCC in previous samples, length of the plateau before the TLC or SCC decreases, and the change in percentages of N, M and L during a number of previous samplings.
A drinking vessel comprising holder and edible object, wherein the holder bears loosely and displaceably on all sides on the vessel edge of the drinking vessel and has at least one through hole for accommodating at least one edible object, wherein the edible object, when being inserted into the through hole, is hold, partially pierces the holder downwards, so that the edible object partially reaches below the vessel edge and is surrounded by the vessel edge in this regard, and, in response to being displaced on the vessel edge, the through hole comprising the edible object secures the holder against falling down in this manner, wherein neither the holder nor the edible object is in contact with a drinking liquid when the drinking vessel is filled at 80 percent by volume, wherein the holder furthermore has one or both of the following features: a) the holder comprising edible object extends beyond the vessel edge outwards by at least one overlap of 3 mm at at least two opposite locations in every position, which can be established by displacing, when being placed on the vessel edge of the drinking vessel, beyond the vessel edge outwards by at least one overlap of 3 mm and/or b) the holder is edible. a) the holder comprising edible object extends beyond the vessel edge outwards by at least one overlap of 3 mm at at least two opposite locations in every position, which can be established by displacing, when being placed on the vessel edge of the drinking vessel, beyond the vessel edge outwards by at least one overlap of 3 mm and/or b) the holder is edible.
A valve for a bag-in-box system or a steel tank system comprising a separate main body (200; 1200) having a through hole, a valve member (302; 1302), which is configured to move between an open state and a closed state, a valve seat (303; 1303) against which the valve member (302; 1302) is configured to create a sealing in the closed state, and a handle unit (301; 1301) connected to the valve member (302; 1302) and configured to move the valve member (302; 1302) back and forth between the open state and the closed state, wherein the valve member (302; 1302) and the valve seat (303; 1303) are arranged within the through hole of the main body (200; 1200), wherein the valve member (302; 1302) further comprises a front connector being a substantially tubular hollow member having an axis of extension from a first end to an opposing second end, wherein the first end is configured to be connected to a filling or discharging coupling and the second end is configured to be connected to the main body, characterized in that the front connector comprises a locking shelf configured to lock the handle unit.
A SERPINA3 inhibitor compound, for use in the prevention and/or therapeutic treatment of a prion or prion-like disease in a subject in need thereof, said compound having the general formula wherein R is a saturated or unsaturated 5- or 6-membered ring containing at least one heteroatom; and R' is a halogen atom or a C 1 -C 4 alkyloxy group substituted with at least one halogen atom. R is a saturated or unsaturated 5- or 6-membered ring containing at least one heteroatom; and R' is a halogen atom or a C 1 -C 4 alkyloxy group substituted with at least one halogen atom.
A thermoplastic resin composition comprising: 100 parts by weight of a polycarbonate resin; 1 part by weight to 10 parts by weight of a first rubber-modified vinyl graft copolymer obtained through graft polymerization of a monomer mixture comprising an aromatic vinyl monomer and a vinyl cyanide monomer to a rubber polymer; 1 part by weight to 10 parts by weight of a second rubber-modified vinyl graft copolymer obtained through graft polymerization of an alkyl (meth)acrylate monomer to a rubber polymer; 1 part by weight to 30 parts by weight of a phosphorus flame retardant; and 0.1 parts by weight to 5 parts by weight of a capsulated fluorine polymer, wherein the first rubber-modified vinyl graft copolymer and the second rubber-modified vinyl graft copolymer are present in a weight ratio of 1:1,5 to 1:2,5. 100 parts by weight of a polycarbonate resin; 1 part by weight to 10 parts by weight of a first rubber-modified vinyl graft copolymer obtained through graft polymerization of a monomer mixture comprising an aromatic vinyl monomer and a vinyl cyanide monomer to a rubber polymer; 1 part by weight to 10 parts by weight of a second rubber-modified vinyl graft copolymer obtained through graft polymerization of an alkyl (meth)acrylate monomer to a rubber polymer; 1 part by weight to 30 parts by weight of a phosphorus flame retardant; and 0.1 parts by weight to 5 parts by weight of a capsulated fluorine polymer, wherein the first rubber-modified vinyl graft copolymer and the second rubber-modified vinyl graft copolymer are present in a weight ratio of 1:1,5 to 1:2,5.
A method for evaluating uncertainty for free space measurements of a radio frequency, RF, device under test comprising laptop mounted equipment, the method comprising: obtaining values of at least one quantity subject to free space measurement expressed as (i) an actual measurement of the 3-D pattern of the device under test and (ii) a calibration of the absolute level of the device under test measurement results, wherein the obtaining comprises performing a measurement of the at least one physically observable quantity and performing a calibration of the measurement of the at least one physically observable quantity by means of using a calibration antenna whose absolute gain/radiation efficiency is known at frequencies of interest; and applying a statistical model to the obtained values to derive values of sources of uncertainty associated with the at least one quantity subject to free space measurement, wherein components associated with the sources of uncertainty are incorporated into the statistical model, and wherein the statistical model is formulated to take into account uncertainty related to use of a laptop ground plane phantom or a laptop embedded equipment UEs. obtaining values of at least one quantity subject to free space measurement expressed as (i) an actual measurement of the 3-D pattern of the device under test and (ii) a calibration of the absolute level of the device under test measurement results, wherein the obtaining comprises performing a measurement of the at least one physically observable quantity and performing a calibration of the measurement of the at least one physically observable quantity by means of using a calibration antenna whose absolute gain/radiation efficiency is known at frequencies of interest; and applying a statistical model to the obtained values to derive values of sources of uncertainty associated with the at least one quantity subject to free space measurement, wherein components associated with the sources of uncertainty are incorporated into the statistical model, and wherein the statistical model is formulated to take into account uncertainty related to use of a laptop ground plane phantom or a laptop embedded equipment UEs.
An intraocular lens insertion device comprising: a main body including a lens placement portion configured to hold an intraocular lens without a load applied thereto, a tapered transition portion configured to deform said intraocular lens, a nozzle portion through which said intraocular lens is discharged, and a lens movement axis that extends through said lens placement portion, said tapered transition portion and said nozzle portion; and a lens push-out mechanism, including a slider and a plunger with a push-out rod, to push said intraocular lens out of said lens placement portion and through the nozzle portion, and said plunger having a proximal end and a distal end and being configured to push said intraocular lens along said lens movement axis from said transition portion and through said nozzle, characterized by said slider having a guide groove and the push-out rod being slidable within said guide groove and the plunger being configured to move relative to the slider and said slider having a lens contact part that is larger in area than the distal end of said plunger and an operating part that projects outwardly from said main body, said slider being configured to move relative to said plunger along said lens movement axis to push said intraocular lens from said lens placement portion into said tapered transition portion to fold said intraocular lens and said push-out rod being configured to move relative to the slider such that the distal end of the plunger protrudes beyond the lens contact part. a main body including a lens placement portion configured to hold an intraocular lens without a load applied thereto, a tapered transition portion configured to deform said intraocular lens, a nozzle portion through which said intraocular lens is discharged, and a lens movement axis that extends through said lens placement portion, said tapered transition portion and said nozzle portion; and a lens push-out mechanism, including a slider and a plunger with a push-out rod, to push said intraocular lens out of said lens placement portion and through the nozzle portion, and said plunger having a proximal end and a distal end and being configured to push said intraocular lens along said lens movement axis from said transition portion and through said nozzle, characterized by said slider having a guide groove and the push-out rod being slidable within said guide groove and the plunger being configured to move relative to the slider and said slider having a lens contact part that is larger in area than the distal end of said plunger and an operating part that projects outwardly from said main body, said slider being configured to move relative to said plunger along said lens movement axis to push said intraocular lens from said lens placement portion into said tapered transition portion to fold said intraocular lens and said push-out rod being configured to move relative to the slider such that the distal end of the plunger protrudes beyond the lens contact part.
System for offline buffering of foam cans comprising at least one entrance and at least one exit; at least one conveyor belt (7, 8), wherein the conveyor belt (7, 8) connects the entrance to the exit; at least one buffer zone placed next to the conveyor belt (7, 8), suitable for receiving the foam cans to be buffered; and a robot comprising a robotic arm, wherein the conveyor belt (7, 8) and the buffer zone are within reach of the robotic arm, wherein the buffer zone comprises at least one stand, the stand comprising several rows, the rows being staggered, and the stand with the rows facing the conveyor belt (7, 8).
A method for controlling a power amplifier of a base station in a wireless communication system based on orthogonal frequency division multiple access, OFDMA, the method comprising: detecting, at a radio frequency, RF, unit, of the base station, power of each of symbols in a frame; identifying, at the RF unit, a first symbol including user data and a second symbol not including user data in the symbols based on a result of the detection; and controlling, at the RF unit, to turn off a bias of the power amplifier in the duration of the second symbol not including user data (S750-S770). detecting, at a radio frequency, RF, unit, of the base station, power of each of symbols in a frame; identifying, at the RF unit, a first symbol including user data and a second symbol not including user data in the symbols based on a result of the detection; and controlling, at the RF unit, to turn off a bias of the power amplifier in the duration of the second symbol not including user data (S750-S770).
A composition comprising: a mixture comprising or, alternatively, consisting of (a) cetylated myristic acid and cetylated oleic acid the mole ratio between the cetylated myristic acid and cetylated oleic acid is comprised in the range from 3:1 to 1.5:1, (b) at least one antioxidant present at a % by weight comprised in the range from 0.001% to 0.5% with respect to the total weight of the composition, (c) a vegetable oil and, optionally, at least one pharmaceutical or food grade additive and/or excipient, wherein said composition is for use in a method for preventive and/or curative treatment of (i.i) a disorder or symptom deriving from and/or related with damaging the gastric mucosa selected from among the group consisting of: gastric ulcers, gastroesophageal reflux (GERD), heartburn; by administering to a subject in need. a mixture comprising or, alternatively, consisting of (a) cetylated myristic acid and cetylated oleic acid the mole ratio between the cetylated myristic acid and cetylated oleic acid is comprised in the range from 3:1 to 1.5:1, (b) at least one antioxidant present at a % by weight comprised in the range from 0.001% to 0.5% with respect to the total weight of the composition, (c) a vegetable oil and, optionally, at least one pharmaceutical or food grade additive and/or excipient, wherein said composition is for use in a method for preventive and/or curative treatment of (i.i) a disorder or symptom deriving from and/or related with damaging the gastric mucosa selected from among the group consisting of: gastric ulcers, gastroesophageal reflux (GERD), heartburn; by administering to a subject in need.
A method for the operation of an exhaust gas aftertreatment system for an internal combustion engine, an exhaust tract being provided with at least one SCR particle filter, the SCR particle filter serving to filter out from the exhaust gas and to store particles contained in an exhaust gas from the internal combustion engine, the SCR particle filter serving to reduce nitrogen oxides contained in the exhaust gas from the internal combustion engine using ammonia as reducing agent, a first reducing agent feed device being provided, which serves for introducing the reducing agent into the exhaust tract upstream of the SCR particle filter, viewed in the direction of flow of the exhaust gas, continuous regeneration of the SCR particle filter being possible using nitrogen dioxide as oxidizing agent, at least one SCR catalytic converter element being arranged downstream of the SCR particle filter and serving to reduce nitrogen oxides likewise contained in the exhaust gas from the internal combustion engine using ammonia as reducing agent, and a second reducing agent feed device being provided, which serves for introducing the reducing agent into the exhaust tract downstream of the SCR particle filter and upstream of the SCR catalytic converter element, a control unit being provided, which serves for regulating and/or controlling the quantity of reducing agent introduced into the exhaust tract by means of the first reducing agent feed device as a function of the temperature (T SCR-PF) of the SCR particle filter, characterized in that no reducing agent is introduced into the exhaust tract by means of the first reducing agent feed device if the actual temperature (T SCR-PF) of the SCR particle filter is lower than a defined particle filter temperature value(T Freigabe,1), a defined quantity of reducing agent (m 1, m 2) being introduced into the exhaust tract by means of the first reducing agent feed device if the actual temperature (T SCR-PF) of the SCR particle filter exceeds the defined particle filter temperature value (T Freigabe,1), and the defined particle filter temperature value (T Freigabe,1) is lower than a SCR response temperature of the SCR particle filter, at which nitrogen oxides contained in the exhaust gas can be reduced by means of the SCR particle filter.
An apparatus for controlling a flow of eggs in an uterine tube of a female patient, the apparatus being characterized by: an implantable constriction device adapted to at least partly constrict at least one wall portion of the uterine tube wall to at least partly constrict the uterine tube, a stimulation device adapted to stimulate the at least one wall portion of the uterine tube wall to further constrict and influence the uterine tube, and a control device, adapted to control the stimulation device to stimulate the uterine tube wall portion, as the constriction device at least partly constricts the uterine tube wall portion, to cause contraction of the uterine tube wall portion to further constrict and influence the flow of eggs in the uterine tube, and wherein the control device is further adapted to control the constriction device to adjust the constriction of the patient's wall portion, and wherein the control device is further adapted to control the constriction and stimulation devices independently of each other. an implantable constriction device adapted to at least partly constrict at least one wall portion of the uterine tube wall to at least partly constrict the uterine tube, a stimulation device adapted to stimulate the at least one wall portion of the uterine tube wall to further constrict and influence the uterine tube, and a control device, adapted to control the stimulation device to stimulate the uterine tube wall portion, as the constriction device at least partly constricts the uterine tube wall portion, to cause contraction of the uterine tube wall portion to further constrict and influence the flow of eggs in the uterine tube, and wherein the control device is further adapted to control the constriction device to adjust the constriction of the patient's wall portion, and wherein the control device is further adapted to control the constriction and stimulation devices independently of each other.
A pearlitic rail having a steel composition consisting of: in terms of percent by mass, C: 0.65% to 1.20%; Si: 0.05% to 2.00%; Mn: 0.05% to 2.00%; and REM: 0.0005% to 0.0500%; S: 0.0020% to 0.0200%. optionally one or more selected from Ca: 0.0005% to 0.0150%, Al: 0.0040% to 0.50%, Co: 0.01% to 1.00%, Cr: 0.01% to 2.00%, Mo: 0.01% to 0.50%, Nb: 0.002% to 0.050%, B: 0.0001% to 0.0050%, Ni: 0.01% to 1.00%, Ti: 0.0050% to 0.0500%, Mg: 0.0005% to 0.0200%, Zr: 0.0001% to 0.2000%, and N: 0.0060% to 0.0200%, with the balance being Fe and inevitable impurities, wherein, among a head portion of the rail, in a head surface portion which ranges from surfaces of head corner portions and a head top portion to a depth of 10 mm or in a portion which ranges from the surfaces of the head corner portions and the head top portion to a depth of 20 mm, 95% or more of a metallographic structure is a pearlite structure, and the hardness Hv of the head surface portion is in a range of 320 to 500.
A device (100; 200; 300) for containing bone graft material, comprising: a mesh outer sleeve extending longitudinally from a proximal end to a distal end and sized and shaped to correspond to a profile of an outer surface of a target bone; and a mesh inner sleeve connected to an interior surface of the outer sleeve, characterised in that the outer sleeve includes a longitudinal slot extending along an entire length thereof and in that an interstitial mesh extends radially away from an exterior surface of the inner sleeve toward the interior surface of the outer sleeve to hold graft material in a bone graft collecting space, wherein the mesh inner sleeve is connected to the interior surface of the outer sleeve via at least one strut so that the bone graft collecting space is defined therebetween, wherein the inner sleeve is sized and shaped to correspond to a profile of a medullary canal of the target bone and an exterior surface of the interstitial mesh is separated from the interior surface of the outer sleeve. a mesh outer sleeve extending longitudinally from a proximal end to a distal end and sized and shaped to correspond to a profile of an outer surface of a target bone; and a mesh inner sleeve connected to an interior surface of the outer sleeve, characterised in that the outer sleeve includes a longitudinal slot extending along an entire length thereof and in that an interstitial mesh extends radially away from an exterior surface of the inner sleeve toward the interior surface of the outer sleeve to hold graft material in a bone graft collecting space, wherein the mesh inner sleeve is connected to the interior surface of the outer sleeve via at least one strut so that the bone graft collecting space is defined therebetween, wherein the inner sleeve is sized and shaped to correspond to a profile of a medullary canal of the target bone and an exterior surface of the interstitial mesh is separated from the interior surface of the outer sleeve.